Statistical Concerns on Vismodegib for Basal Cell Carcinoma Meta-Analysis-Reply
- PMID: 28196183
- DOI: 10.1001/jamadermatol.2016.5688
Statistical Concerns on Vismodegib for Basal Cell Carcinoma Meta-Analysis-Reply
Comment on
-
Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies.JAMA Dermatol. 2016 Jul 1;152(7):816-24. doi: 10.1001/jamadermatol.2016.0780. JAMA Dermatol. 2016. PMID: 27096888
-
Statistical Concerns on Vismodegib for Basal Cell Carcinoma Meta-analysis.JAMA Dermatol. 2017 Apr 1;153(4):337. doi: 10.1001/jamadermatol.2016.5689. JAMA Dermatol. 2017. PMID: 28196186 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources